Multi-institutional randomized phase II trial of gefitinib for previously treated patients with advanced non-small-cell lung cancer (The IDEAL 1 Trial) [corrected]. (Q34533636)
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | No label defined |
||
| English | Multi-institutional randomized phase II trial of gefitinib for previously treated patients with advanced non-small-cell lung cancer (The IDEAL 1 Trial) [corrected]. |
scientific article |
Statements
Multi-institutional randomized phase II trial of gefitinib for previously treated patients with advanced non-small-cell lung cancer (The IDEAL 1 Trial) [corrected] (English)
Jean-Yves Douillard
Masahiro Fukuoka
Seiji Yano
Tomohide Tamura
Kazuhiko Nakagawa
Yutaka Nishiwaki
Johan Vansteenkiste
Shinzoh Kudoh
Danny Rischin
Richard Eek
Takeshi Horai
Kazumasa Noda
Ichiro Takata
Egbert Smit
Steven Averbuch
Angela Macleod
Andrea Feyereislova